Profile
DYAI VRTX REGN VRNA ARGX ALNY
Company Name Dyadic International, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $32.14M $122.53B $76.58B $72.68B $50.22B $43.35B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Mark A. Emalfarb Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
DYAI VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
DYAI VRTX REGN VRNA ARGX ALNY
Last Close $0.89 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.97 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.75 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -54.82 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 18.67 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
DYAI VRTX REGN VRNA ARGX ALNY
1 Month Return -16.82 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 11.94 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -14.42 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -41.45 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -49.14 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -27.05 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DYAI VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4628505 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.16 % - - -
Profitability
DYAI VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 42.22 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -62.95 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -537.2 % 21.81 % 14.07 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -94.31 % 19.59 % 9.28 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 102.24 % 111.4 % 141.65 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -273.42 % 34.06 % 25.75 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -91.43 % 202.64 % 187.41 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 2.76 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 2.15 0.4 0.34 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 5016.21 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 22.52 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.13 14.55 49.28 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.13 13.06 40.37 -0.85 5.58 1.68
Cash Per Share TTM 29.72 % 2459.7 % 18334.11 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -176.09 % 31.71 % 35.36 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -91.43 % 202.64 % 187.41 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -6.94 36.72 18.43 -995.27 128.45 195.85
Price To Operating Cash Flows Ratio TTM -6.62 32.86 15.05 -126.33 145.01 162.25
Price Cash Flow Ratio TTM -6.62 32.86 15.05 -126.33 145.01 162.25
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to DYAI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 340.96
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 151.14
VXF Vanguard Extended Market Index Fund 0.00021 217.96
IWC iShares Micro-Cap ETF 0 168.85
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 126.63
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 118.21
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00008 114.86
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.84
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00003 52.46
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00003 52.45
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.45
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.01
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.34
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0 31.94
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.22
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.82
VTSAX Vanguard Total Stock Market Index Fund 0.00003 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00021 165.43
VITSX Vanguard Total Stock Market Index Fund 0.00003 166.06
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000152504 16.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00021 165.44
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 479.23
VEMPX Vanguard Extended Market Index InstlPlus 0.00021 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 311.51
Unlock